Hemostatic factors in the Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Elevated levels of factor VII (FVII) and fibrinogen (Fb) have been reported as risk factors for coronary heart disease in middle-aged and older adults. The purpose of this study was to determine whether increased levels of these and other hemostatic factors (FVIII, von Willebrand factor [vWF]) were associated with other coronary risk factors in young adults participating in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Hemostatic factors were measured in 1724 participants aged 23 to 35 years who were roughly balanced by sex and race (black/white). Fb was greater in women than men (black, 288 versus 253 mg/dL; white, 267 versus 240 mg/dL; overall P < .05 by Scheffé multiple-comparison test), and FVIII and vWF were higher in blacks than in whites (FVIII in men, 103% versus 88%, and in women, 104% versus 91%; vWF in men, 114% versus 98%, and in women, 117% versus 99%; P < .05). The latter factors were lower in those with blood group O, but within each blood group (except group A), blacks had significantly higher levels of FVIII and vWF. Fb was positively correlated with body mass index (r = .27 to .48, P < .001), total cholesterol (r = .13 to .17, P < .05), and low-density lipoprotein cholesterol (r = .15 to .22, P < .01) in all groups and with blood pressure, triglycerides, and cigarette smoking in white men. FVII correlated positively with cholesterol (r = .12 to .29, P < .05) and triglycerides (r = .23 to .32, P < .001) in all groups and with low-density lipoprotein in whites.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  L. Wilkins Natural history of aortic and coronary atherosclerotic lesions in youth. Findings from the PDAY Study. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[2]  E. Ernst,et al.  Fibrinogen as a Cardiovascular Risk Factor , 1993, Annals of Internal Medicine.

[3]  A. Folsom,et al.  Distributions of hemostatic variables in blacks and whites: population reference values from the Atherosclerosis Risk in Communities (ARIC) Study. , 1992, Ethnicity & disease.

[4]  A. Banerjee,et al.  A Six Year Prospective Study of Fibrinogen and Other Risk Factors Associated with Mortality in Stable Claudicants , 1992, Thrombosis and Haemostasis.

[5]  E. Ernst,et al.  Fibrinogen and Viscosity as Risk Factors for Subsequent Cardiovascular Events in Stroke Survivors , 1992, Annals of Internal Medicine.

[6]  L. Tavazzi,et al.  The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[7]  A. Folsom,et al.  Association of coagulation factors and inhibitors with carotid artery atherosclerosis. Early results of the Atherosclerosis Risk in Communities (ARIC) Study. , 1992, Annals of epidemiology.

[8]  U. Keil,et al.  Determinants of plasma fibrinogen: relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex. Results from the second MONICA Augsburg survey 1989-1990. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[9]  R. Miller,et al.  Correlation of factor VII activity and antigen with cholesterol and triglycerides in healthy young adults. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[10]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.

[11]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (1). , 1992, The New England journal of medicine.

[12]  A. Folsom,et al.  Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. , 1991, Atherosclerosis.

[13]  J. Jansson,et al.  von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. , 1991, British heart journal.

[14]  T. Meade,et al.  A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[15]  Hultin Mb Fibrinogen and factor VII as risk factors in vascular disease. , 1991 .

[16]  Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. A preliminary report from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. , 1990, JAMA.

[17]  A. Folsom,et al.  Hemostatic variables in Japanese and Caucasian men. Plasma fibrinogen, factor VIIc, factor VIIIc, and von Willebrand factor and their relations to cardiovascular disease risk factors. , 1989, American journal of epidemiology.

[18]  K. Mann,et al.  Factor VII assays, plasma triglyceride levels, and cardiovascular disease risk. , 1989, Arteriosclerosis.

[19]  H. Prydz,et al.  Effect of alteration in triglyceride levels on factor VII-phospholipid complexes in plasma. , 1989, Arteriosclerosis.

[20]  W. Lawson,et al.  Elevation of factor VII activity and mass in young adults at risk of ischemic heart disease. , 1989, Journal of the American College of Cardiology.

[21]  K. Wu,et al.  ARICHemostasis Study - I. Development of a Blood Collection and Processing System Suitable for Multicenter Hemostatic Studies , 1989, Thrombosis and Haemostasis.

[22]  M. Hultin,et al.  Factor VII activity state in coronary artery disease. , 1988, The Journal of laboratory and clinical medicine.

[23]  S B Hulley,et al.  CARDIA: study design, recruitment, and some characteristics of the examined subjects. , 1988, Journal of clinical epidemiology.

[24]  S. Humphries,et al.  ROLE OF GENETIC VARIATION AT THE FIBRINOGEN LOCUS IN DETERMINATION OF PLASMA FIBRINOGEN CONCENTRATIONS , 1987, The Lancet.

[25]  W. Marks,et al.  The effect of ABO blood group on the diagnosis of von Willebrand disease. , 1987, Blood.

[26]  S. Thompson,et al.  HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY , 1986, The Lancet.

[27]  Gerald S. Berenson,et al.  Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: the Bogalusa heart study , 1986 .

[28]  Warnick Gr Enzymatic methods for quantification of lipoprotein lipids. , 1986 .

[29]  G. Warnick Enzymatic methods for quantification of lipoprotein lipids. , 1986, Methods in enzymology.

[30]  G. Assmann,et al.  Epidemiological Study on Factor VII, Factor VIII and Fibrinogen in an Industrial Population - II. Baseline Data on the Relation to Blood Pressure, Blood Glucose, Uric Acid, and Lipid Fractions , 1985, Thrombosis and Haemostasis.

[31]  I. Hjermann,et al.  A novel form of factor VII in plasma from men at risk for cardiovascular disease , 1985, British journal of haematology.

[32]  H. Schulte,et al.  Epidemiological Study on Factor VII, Factor VIII and Fibrinogen in an Industrial Population: I. Baseline Data on the Relation to Age, Gender, Body-Weight, Smoking, Alcohol, Pill-Using, and Menopause , 1985, Thrombosis and Haemostasis.

[33]  L. Wilhelmsen,et al.  Fibrinogen as a risk factor for stroke and myocardial infarction. , 1984, The New England journal of medicine.

[34]  M. Sirridge,et al.  Laboratory Evaluation of Hemostasis and Thrombosis , 1983 .

[35]  J. Albers,et al.  Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. , 1982, Clinical chemistry.

[36]  S. Thompson,et al.  HÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDY , 1980, The Lancet.

[37]  S. Thompson,et al.  Haemostatic function and cardiovascular death: early results of a prospective study. , 1980, Lancet.

[38]  A. P. Haines,et al.  Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. , 1979, British medical journal.

[39]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[40]  J. Mcnamara,et al.  Coronary artery disease in combat casualties in Vietnam. , 1971, JAMA.

[41]  W F ENOS,et al.  Coronary disease among United States soldiers killed in action in Korea; preliminary report. , 1953, Journal of the American Medical Association.